purmorphamine,
Purmorphamine,
483367-10-8,
2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine,
UNII-PB12M2F8KY,
Shh Signaling Antagonist VI,
PB12M2F8KY,
CHEMBL1221984,
CHEBI:63053,
9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6-amine,
9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine,
2-(1-Napthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine,
9-cyclohexyl-N-(4-morpholinophenyl)-2-(naphthalen-1-yloxy)-9H-purin-6-amine,
9-Cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-9H-purin-6-amine,
Purmorphamine [MI],
MolMap_000073,
AC1NR49A,
9H-Purin-6-amine, 9-cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-,
MLS006010334,
SCHEMBL1548273,
CTK1D4950,
KS-00000XPM,
AOB5391,
DTXSID20415293,
EX-A348,
FYBHCRQFSFYWPY-UHFFFAOYSA-N,
HMS3650O20,
HMS3651D16,
BCP03687,
BDBM50324671,
HSCI1_000224,
IN1132,
MFCD09037557,
NSC747596,
s3042,
ZINC14806830,
AKOS024458218,
CS-1135,
LS41103,
NSC-747596,
RL03799,
SB19498,
NCGC00344053-01,
NCGC00344053-09,
4CA-1056,
AK175828,
BC600598,
DA-05531,
HY-15108,
QC-10453,
SMR004701397,
AB0032036,
RT-015157,
FT-0674154,
SW219909-1,
X5299,
A11480,
W-5393,
SR-01000946316,
J-519503,
SR-01000946316-1,
BRD-K73397362-001-01-7,
9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine,
9-Cyclohexyl-N-[4-(morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine,
cc-676,
C31H32N6O2,
2- -6- -9-CYCLOHEXYLPURINE,
ACN-029570,
CID5284329,
A8228,
C470893,
9H-Purin-6-amine, 9-cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-,